Having a firm that understands the technology industry can make an important difference when it is time to explain to investors, regulators, analysts and financial institutions the special aspects of a technology business. Our representation of a broad spectrum of technology and life sciences companies has given Fenwick & West unusual depth of experience in public offerings, corporate governance and other securities matters. We are one of the most active law firms in the country in representing technology and life sciences companies in their initial public offerings and other equity and debt offerings. We also represent many of the most active investment banking firms for technology transactions. In addition, we have an active practice counseling publicly-traded technology companies regarding ongoing corporate governance, disclosure and securities law issues.
In addition to representing the leading technology and life sciences companies and underwriters in capital markets transactions, Fenwick’s securities group works closely with our executive compensation group to handle sensitive matters of executive compensation in a dynamic regulatory environment, and with our securities litigation group to conduct internal investigations and advise on other governance related matters. We also work closely with our mergers & acquisitions group to enable the structuring and smooth completion of transactions.